Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old
Simrit Parmar, Lynn M. Rundhaugen, Larry Boehlke, Mary Beth Riley, Chadi Nabhan, Adekunle Raji, John L. Frater, Martin S. Tallman
Dive into the research topics of 'Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old'. Together they form a unique fingerprint.